2.625

2.54% 0.065

After Hours: 2.63 0.005 +0.19%

Virax Biolabs Group Ltd (VRAX)

Overview News Price History Discussions Forecast

Virax Biolabs Group Ltd stock is traded at $2.625, with a volume of 21,821. It is up +2.54% in the last 24 hours and down -11.91% over the past month. Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Previous Close:

$2.56

Open:

$2.54

24h Volume:

21,821

Relative Volume:

0.01

Market Cap:

$2.09M

Revenue:

$12,400

Net Income/Loss:

$-5.03M

P/E Ratio:

-0.1552

EPS:

-16.9112

Net Cash Flow:

$-4.87M

1W Performance:

-6.91%

1M Performance:

-11.91%

6M Performance:

-49.76%

1Y Performance:

-82.69%

1-Day Range:

$2.54

$2.635

1-Week Range:

$2.52

$2.92

52-Week Range:

$2.50

$21.75

Virax Biolabs Group Ltd Stock (VRAX) Company Profile

Name

Virax Biolabs Group Ltd

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-10-01

Latest SEC Filings

VRAX's Discussions on Twitter

Compare VRAX vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VRAX Virax Biolabs Group Ltd	2.625	2.75M	12,400	-5.03M	-4.87M	-16.91
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-31-25	Initiated	H.C. Wainwright	Buy

Virax Biolabs Group Ltd Stock (VRAX) Latest News

Sep 06, 2026

Virax Biolabs Shareholders Approve Major Capital Increase but Reject Governance Overhaul - TipRanks

Aug 26, 2026

Virax Biolabs (NASDAQ: VRAX) OKs share surge as charter overhaul fails - Stock Titan

Aug 26, 2026

Aug 20, 2026

Join Virax's Live Investor Webinar: Advancing Immune Diagnostics, Clinical Development and Commercial Execution - Yahoo Finance

Aug 20, 2026

Aug 19, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Aug 19, 2026

What's going on in today's after hours session - ChartMill

Aug 19, 2026

VRAX Stock Whipsaws As Traders Target Volatile Biotech Play - StocksToTrade

Aug 19, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Aug 19, 2026

Aug 18, 2026

Virax Biolabs Posts Updated Q3 2026 Investor Presentation - TipRanks

Aug 18, 2026

Virax Biolabs (VRAX) updates Q3 2026 investor presentation - Stock Titan

Aug 18, 2026

Aug 16, 2026

MSN Money - MSN

Aug 16, 2026

Aug 09, 2026